Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats

Mahalaxmi Mohan1, Sarika Kamble, Prakash Gadhi

  • 1Department of Pharmacology, MGV's Pharmacy College, Panchavati, Nashik 422 003, Maharashtra, India. mm_nasik@yahoo.co.in

Insights

Solanum torvum extract significantly protected against doxorubicin-induced nephrotoxicity in rats. It reduced kidney damage markers and enhanced antioxidant enzymes, suggesting a protective role.

Area of Science:

  • Pharmacology
  • Toxicology
  • Natural Product Research

Background:

  • Nephrotoxicity is a significant adverse effect of anthracycline antibiotics like doxorubicin.
  • Oxidative stress is a primary mechanism underlying doxorubicin-induced kidney damage.

Purpose of the Study:

  • To investigate the protective potential of Solanum torvum against doxorubicin-induced nephrotoxicity in a rat model.
  • To evaluate the biochemical and histopathological effects of Solanum torvum in mitigating kidney damage.

Main Methods:

  • Wistar rats were administered doxorubicin (DOX) alone or in combination with varying doses of Solanum torvum extract.
  • Nephrotoxicity was assessed by measuring serum creatinine and blood urea nitrogen (BUN) levels.
  • Kidney tissue antioxidant enzymes, superoxide dismutase (SOD) and catalase (CAT), were quantified. Histopathological examination of kidney tissues was performed.

Main Results:

  • Solanum torvum treatment significantly reduced elevated serum creatinine and BUN levels caused by doxorubicin.
  • The extract significantly increased the activity of antioxidant enzymes SOD and CAT in kidney tissues.
  • Histopathological analysis revealed that Solanum torvum reversed doxorubicin-induced kidney damage, including tubular necrosis and glomerular congestion.

Conclusions:

  • Solanum torvum exhibits significant nephroprotective effects against doxorubicin-induced kidney injury in rats.
  • The protective mechanism likely involves the mitigation of oxidative stress and enhancement of endogenous antioxidant defenses.
  • Solanum torvum demonstrates potential as a therapeutic agent for preventing doxorubicin-related nephrotoxicity.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...